These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 30885552)

  • 1. Impact Of Vulvovaginal Atrophy Of Menopause In Spanish Women: Prevalence And Symptoms According To The EVES Study.
    Palacios S; González SP; Fernández-Abellán M; Manubens M; García-Alfaro P;
    Sex Med; 2019 Jun; 7(2):207-216. PubMed ID: 30885552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of vulvovaginal atrophy of menopause: prevalence and symptoms in Italian women according to the EVES study.
    Nappi RE; Seracchioli R; Salvatore S; Cagnacci A; Di Paolantonio T; Busacca M;
    Gynecol Endocrinol; 2019 May; 35(5):453-459. PubMed ID: 30700188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The European Vulvovaginal Epidemiological Survey (EVES): prevalence, symptoms and impact of vulvovaginal atrophy of menopause.
    Palacios S; Nappi RE; Bruyniks N; Particco M; Panay N;
    Climacteric; 2018 Jun; 21(3):286-291. PubMed ID: 29553288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The European Vulvovaginal Epidemiological Survey (EVES): impact on sexual function of vulvovaginal atrophy of menopause.
    Particco M; Djumaeva S; Nappi RE; Panay N; Palacios S;
    Menopause; 2020 Apr; 27(4):423-429. PubMed ID: 32068686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Symptom severity and quality of life in the management of vulvovaginal atrophy in postmenopausal women.
    Panay N; Palacios S; Bruyniks N; Particco M; Nappi RE;
    Maturitas; 2019 Jun; 124():55-61. PubMed ID: 31097180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vulvovaginal atrophy of menopause and its impact on sexual function in an Italian clinical cohort of post-menopausal women.
    Nappi RE; Guida M; Marchesoni D; Cianci A; Pellegrino A; Remorgida V; Di Paolantonio T; Benedetti Panici P;
    J Obstet Gynaecol; 2021 Feb; 41(2):290-297. PubMed ID: 33432869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The burden of vulvovaginal atrophy on women's daily living: implications on quality of life from a face-to-face real-life survey.
    Nappi RE; Palacios S; Bruyniks N; Particco M; Panay N;
    Menopause; 2019 May; 26(5):485-491. PubMed ID: 30422932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of vulvovaginal atrophy on women's quality of life from an Italian cohort of the EVES study.
    Nappi RE; Di Carlo C; Becorpi AM; Gambacciani M; De Seta F; Ribaldone R; Benedetto C; Paoletti AM;
    J Obstet Gynaecol; 2020 May; 40(4):512-519. PubMed ID: 31496326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The European Vulvovaginal Epidemiological Survey (EVES). Impact of history of breast cancer on prevalence, symptoms, sexual function and quality of life related to vulvovaginal atrophy.
    Nappi RE; Palacios S; Bruyniks N; Particco M; Panay N;
    Gynecol Endocrinol; 2021 Jan; 37(1):78-82. PubMed ID: 32856973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vulvar and vaginal atrophy in four European countries: evidence from the European REVIVE Survey.
    Nappi RE; Palacios S; Panay N; Particco M; Krychman ML
    Climacteric; 2016 Apr; 19(2):188-97. PubMed ID: 26581580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between changes in vulvar-vaginal atrophy and changes in sexual functioning.
    Pinkerton JV; Bushmakin AG; Komm BS; Abraham L
    Maturitas; 2017 Jun; 100():57-63. PubMed ID: 28539177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Gynogram: A Multicentric Validation of a New Psychometric Tool to Assess Coital Pain Associated With VVA and Its Impact on Sexual Quality of Life in Menopausal Women.
    Nappi RE; Graziottin A; Mollaioli D; Limoncin E; Ciocca G; Sansone A; Meriggiola MC; Becorpi AM; Maffei S; Russo N; Jannini EA;
    J Sex Med; 2021 May; 18(5):955-965. PubMed ID: 33896758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vulvar and vaginal atrophy as viewed by the Spanish REVIVE participants: symptoms, management and treatment perceptions.
    Palacios S; Cancelo MJ; Castelo Branco C; Llaneza P; Molero F; Borrego RS
    Climacteric; 2017 Feb; 20(1):55-61. PubMed ID: 28042734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Addressing Vulvovaginal Atrophy (VVA)/Genitourinary Syndrome of Menopause (GSM) for Healthy Aging in Women.
    Nappi RE; Martini E; Cucinella L; Martella S; Tiranini L; Inzoli A; Brambilla E; Bosoni D; Cassani C; Gardella B
    Front Endocrinol (Lausanne); 2019; 10():561. PubMed ID: 31496993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Association Between Vulvovaginal Atrophy Symptoms and Quality of Life Among Postmenopausal Women in the United States and Western Europe.
    DiBonaventura M; Luo X; Moffatt M; Bushmakin AG; Kumar M; Bobula J
    J Womens Health (Larchmt); 2015 Sep; 24(9):713-22. PubMed ID: 26199981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Convergent-Divergent Validity and Correlates of the Day-to-Day Impact of Vaginal Aging Domain Scales in the MsFLASH Vaginal Health Trial.
    Hunter MM; Guthrie KA; Larson JC; Reed SD; Mitchell CM; Diem SJ; LaCroix AZ; Huang AJ
    J Sex Med; 2020 Jan; 17(1):117-125. PubMed ID: 31812686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamic quadripolar radiofrequency treatment of vaginal laxity/menopausal vulvo-vaginal atrophy: 12-month efficacy and safety.
    Vicariotto F; DE Seta F; Faoro V; Raichi M
    Minerva Ginecol; 2017 Aug; 69(4):342-349. PubMed ID: 28608667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vulvar and vaginal atrophy in postmenopausal women: findings from the REVIVE (REal Women's VIews of Treatment Options for Menopausal Vaginal ChangEs) survey.
    Kingsberg SA; Wysocki S; Magnus L; Krychman ML
    J Sex Med; 2013 Jul; 10(7):1790-9. PubMed ID: 23679050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Women's EMPOWER Survey: Women's Knowledge and Awareness of Treatment Options for Vulvar and Vaginal Atrophy Remains Inadequate.
    Krychman M; Graham S; Bernick B; Mirkin S; Kingsberg SA
    J Sex Med; 2017 Mar; 14(3):425-433. PubMed ID: 28202319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sexual function after fractional microablative CO₂ laser in women with vulvovaginal atrophy.
    Salvatore S; Nappi RE; Parma M; Chionna R; Lagona F; Zerbinati N; Ferrero S; Origoni M; Candiani M; Leone Roberti Maggiore U
    Climacteric; 2015 Apr; 18(2):219-25. PubMed ID: 25333211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.